BERMAN ROBERT ANDREW (Chief Executive Officer) received a stock award from ENVVENO MEDICAL CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/2/2021ACC: 0001493152-21-030335
DirectorOfficer· Chief Executive Officer
Since Sep 2018
+549.78K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
549.78K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
2585.3%
11/30/2021
7.74K→207.74K
Total
Net shares
+200K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/30/2021 | A · Award | +200K | — | — | 2585.3% | 7.74K | 207.74K |
| Total | +200K | $0.00 | ||||||
Derivative Transactions1
Stock Options
Direct
Converts to
Common Stock
349.78K shares
Shares
+349.78K
Strike price
6.70
Held after
349.78K
Exercisable
—
11/30/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock349.78K shares | 11/30/2021 | A · Award | +349.78K | 6.70 | — | 349.78K |